Discrimination of healthy and cancer cells of the bladder by metabolic state, based on autofluorescence

S. Palmer; Karina Litvinova; E. U. Rafailov; G. Nabi

doi:10.1117/12.2077218

26 February 2015 Discrimination of healthy and cancer cells of the bladder by metabolic state, based on autofluorescence

S. Palmer, Karina Litvinova, E. U. Rafailov, G. Nabi

Author Affiliations +

Proceedings Volume 9303, Photonic Therapeutics and Diagnostics XI; 93030T (2015) https://doi.org/10.1117/12.2077218
Event: SPIE BiOS, 2015, San Francisco, California, United States

Abstract

Bladder cancer is among the most common cancers worldwide (4th in men). It is responsible for high patient morbidity and displays rapid recurrence and progression. Lack of sensitivity of gold standard techniques (white light cystoscopy, voided urine cytology) means many early treatable cases are missed. The result is a large number of advanced cases of bladder cancer which require extensive treatment and monitoring. For this reason, bladder cancer is the single most expensive cancer to treat on a per patient basis. In recent years, autofluorescence spectroscopy has begun to shed light into disease research. Of particular interest in cancer research are the fluorescent metabolic cofactors NADH and FAD. Early in tumour development, cancer cells often undergo a metabolic shift (the Warburg effect) resulting in increased NADH. The ratio of NADH to FAD (“redox ratio”) can therefore be used as an indicator of the metabolic status of cells. Redox ratio measurements have been used to differentiate between healthy and cancer breast cells and to monitor cellular responses to therapies. Here, we have demonstrated, using healthy and bladder cancer cell lines, a statistically significant difference in the redox ratio of bladder cancer cells, indicative of a metabolic shift. To do this we customised a standard flow cytometer to excite and record fluorescence specifically from NADH and FAD, along with a method for automatically calculating the redox ratio of individual cells within large populations. These results could inform the design of novel probes and screening systems for the early detection of bladder cancer.

Citation Download Citation

S. Palmer, Karina Litvinova, E. U. Rafailov, and G. Nabi "Discrimination of healthy and cancer cells of the bladder by metabolic state, based on autofluorescence", Proc. SPIE 9303, Photonic Therapeutics and Diagnostics XI, 93030T (26 February 2015); https://doi.org/10.1117/12.2077218

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available